DRUG DISCOVERY FEATURED ARTICLES & APPLICATIONS

  • From Discovery To Development: GS Expression System For Next-Generation Biologics
    From Discovery To Development: GS Expression System For Next-Generation Biologics

    Compared to traditional antibody expression, where routine purification and analytical strategies have been established over the last few years, next-generation biologics have complex designs. If you are first in class or you have a very bespoke up- and downstream process, it also means you will have bigger hurdles to overcome when it comes to regulatory support and filing. At Lonza, these challenges are addressed with the GS™ expression platform.

  • Digging Into The Details: Commonly Asked Questions About Lonza’s XS And GS Expression Systems

    No single strain or vector is capable of being the best expression option for all types of biopharmaceuticals. Experts from Lonza answers questions about the proprietary expression platforms the company has assembled to rapidly generate high-producing cell lines for biological candidates.

  • How Pacira Pharma Is Working To Help Curb The Opioid Epidemic

    The most effective way to stop the epidemic of opioid dependence is to eliminate the use of these highly addictive drugs after surgery. This was the goal of Pacira Pharmaceuticals, a specialty pharmaceutical company focused on the development of non-opioid products for postsurgical pain control, when it developed its injectable suspension, EXPAREL®.

  • Early Implementation Of Quality By Design For Biological Product Development

    The idea of thinking in terms of “operational excellence” is a relatively new idea for the biopharmaceutical industry. The enormous uncertainty associated with bringing a biological drug product from discovery to approval almost precludes the thought of forward-thinking in terms of what makes a quality product, especially during early-stage development. However, extensive product knowledge is gathered during early development, and crucial decisions are made in terms moving the science forward to generate the data required to meet your business objectives.

  • CAR T-Cell Therapy: The Road Ahead

    In recent years, we have witnessed a meteoric rise in clinical studies of cancer immunotherapies, catapulting immuno-oncology into one of the fastest growing and dynamic areas in pharmaceutical development today.

More From Featured Articles

FEATURED PRODUCTS AND SERVICES

Nanosep MF Centrifugal Devices Nanosep MF Centrifugal Devices
Nanosep MF Centrifugal Devices concentrate, purify and desalt peptides, proteins, oligonucleotides, DNA and RNA as well as clean up labeling and PCR reactions...
Drug Process Development Drug Process Development

Althea’s complete range of drug Process Development capabilities offers the tools to address your needs. We develop processes for producing small quantities of proteins for early testing or establish robust, reliable and scalable processes that enable a strong commercial advantage. Althea also provides access to a proprietary drug delivery platform, called Crystalomics® technology, for the development of alternative drug delivery formulations of second generation drug substances.

Solution Tubes Solution Tubes
SuperClear Sustainable Solution tubes eliminate most common problems associated with
Stereotaxic Accessories for Mice Stereotaxic Accessories for Mice
The Mouse and Neonatal Rat Adaptor was specifically redesigned and machined to securely hold the
Screening Reagent Screening Reagent
The Pan-Enterovirus reagent has an atypical staining pattern in the cytoplasm that should appear speckled and
Benchtop Microcentrifuges Benchtop Microcentrifuges
Microcentaur Benchtop Microcentrifuges feature microtube rotor with a maximum speed of 13,000 rpm and 13,400 x max RCF
More Featured Products

INDUSTRY EVENTS

BioNetwork West 2016 October 5 - 7, 2016
Laguna Niguel, CA
Pediatric Clinical Trials: Special Considerations and Requirements October 6, 2016
1pm-2:30pm EDT, Online Training
Biosimilars: Preparing For Opportunities And Challenges October 11, 2016
1pm-2:30pm EDT, Online Training
Medical Device Design Controls 101 – A Practical Crash Course October 12, 2016
1pm-2:30pm EDT, Online Training
More Events....

 UPCOMING TRAINING COURSES

Pediatric Clinical Trials: Special Considerations and Requirements October 6, 2016
1pm-2:30pm EDT, Online Training
Biosimilars: Preparing For Opportunities And Challenges October 11, 2016
1pm-2:30pm EDT, Online Training
Medical Device Design Controls 101 – A Practical Crash Course October 12, 2016
1pm-2:30pm EDT, Online Training
The Top Method Validation Mistakes – And How to Avoid Them October 14, 2016
1pm-2:30pm EDT, Online Training
More Upcoming Courses

PREMIER SERVICE PROVIDER